Form:
Eye Drops
Concentration:
0.005%, 0.5%
Pack:
2.5 ml
Composition:
latanoprost, Timolol as Maleate
Eye drops.
Reducing elevated intraocular pressure in conditions such as ocular hypertension and chronic open-angle glaucoma.
Combination therapy working on two different mechanisms by increasing aqueous humor fluid uveoscleral outflow by 50% and decrease excessive production of aqueous humor fluid.
Maintains a 24 hour consistent IOP control.
Maximum effectiveness with additional reductions in IOP more than monotherapy.
One drop in the affected eye(s) once a day.
Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of Ophthalmology, ENT (Ear, Nose & Throat ) , respiratory, and Dermatology. After many years of success.
